Hong Xiang Shi
Directeur/Bestuurslid bij Zhejiang Cezanne Pharmaceutical Technology Co. Ltd.
Oorsprong van het eerstegraads netwerk van Hong Xiang Shi
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Zhejiang Cezanne Pharmaceutical Technology Co. Ltd.
 Zhejiang Cezanne Pharmaceutical Technology Co. Ltd. BiotechnologyHealth Technology Zhejiang Cezanne Pharmaceutical Technology Co. Ltd. engages in the research and development of automated immune cells in vitro amplification system. It also involves in the import and export of products. The company was founded on May 19, 2011 and is headquartered in Shaoxing, China.
4
| Subsidiary | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Hong Xiang Shi via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| VCANBIO CELL & GENE ENGINEERING CORP., LTD | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Eastern Union Stem Cell & Gene Engineering Co., Ltd.
 Eastern Union Stem Cell & Gene Engineering Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Eastern Union Stem Cell & Gene Engineering Co., Ltd. preparation, detection and storage of stem cell sources. It also offers technical services. The company was founded on April 11, 2003 and is headquartered in Huzhou, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Vcanland Holding Group Co. Ltd.
 Vcanland Holding Group Co. Ltd. Real Estate DevelopmentFinance Vcanland Holding Group Co. Ltd. is a Chinese company that engages in real estate development activities. The company is based in Tianjin, China. | Real Estate Development | Director/Board Member | |
Union Stem Cell & Gene Engineering Co., Ltd.
 Union Stem Cell & Gene Engineering Co., Ltd. BiotechnologyHealth Technology Union Stem Cell & Gene Engineering Co., Ltd. engages in the development of stem cell therapeutic products. Its business activities include stem cell resource conservation, stem cell clinical transplant, and research and development of monoclonal antibodies treatment and gene chip. The company was founded on February 16, 2001 and is headquartered in Tianjin, China. | Biotechnology | Chairman |
Statistieken
Internationaal
| China | 5 |
Sectoraal
| Commercial Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Operationeel
| Director/Board Member | 8 |
| Chairman | 3 |
| Chief Executive Officer | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Yong Wang | 5 |
| Bing Qing Fan | 3 |
| Jie Jing | 1 |
| Da Mao Zhuang | 1 |
- Beurs
- Insiders
- Hong Xiang Shi
- Bedrijfsconnecties
